Notice of Annual General Meeting

22. Apr 2021 | 2 min read

The 2021 Annual General Meeting of Gentian Diagnostics AS will be held on 4 May
2021 at 10:00 (CEST) at Bjørnåsveien 5, 1596 Moss.

IMPORTANT INFORMATION REGARDING LIMITATION OF PHYSICAL PRESENCE
Due to the COVID 19 pandemic, the board encourages shareholders to not
physically attend the general meeting. Instead, shareholders are encouraged to
authorize the chairperson of the board to vote on their behalf or use the
enclosed proxy form. By using a proxy with voting instructions, the shareholders
will vote on the specific issues without personal attendance.

Physical attendance increases the risk of infection spreading. Gentian
Diagnostics AS wants to contribute to reducing the spread of COVID 19 and we
hope our shareholders will support this by not physically attending the general
meeting.

Please find the notice including appendices enclosed. The document will also be
made available on www.gentian.com.

530794_GDAS Notice AGM 2021

 

  530794_GDAS Notice AGM 2021.pdf

 

You may also read


Feb 12, 2026 - Ole Sørlie

Gentian Diagnostics: Key information relating to the proposed cash dividend

Moss, 12 February 2026 The Board of Directors of Gentian Diagnostics ASA proposes a dividend of NOK 0.60 per..

Feb 11, 2026 - Ole Sørlie

Update on the development of the NT-proBNP assay

Gentian Diagnostics ASA announces an update on the development of its NT proBNP assay. Recent investigations..

Feb 11, 2026 - Ole Sørlie

Gentian Diagnostics: Fourth quarter 2025 report

Moss, 11 February 2026 Gentian Diagnostics ASA, a fast-growing developer and manufacturer of diagnostic..